~~<i id='B1B3EAB435'><strike id='B1B3EAB435'><tt id='B1B3EAB435'><pre id='B1B3EAB435'></pre></tt></strike></i>~~

Home» knowledge» focus

focus

author：hotspot 2025-09-30 20:05:11 Page View：8751

Senate health committee Chair Bernie Sanders — Sen. Berne Sanders (I-Vt.) Kevin Dietsch/Getty Images

WASHINGTON — Sen. Bernie Sanders (I-Vt.) has a new corporate target: the food industry.

Sanders held a hearing today on diabetes that implicated both the food and drug industries in what the American Diabetes Association estimates is a $413 billion annual cost to the health care system. That’s up 27% over the past six years, he said, and he warned that new weight loss drugs could send health care spending to the stratosphere.

But the food industry received more attention, especially from Sanders, than the drugmakers and drug middlemen.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： HHS suspends federal funding for EcoHealth Alliance
Next article： Anesthesiologist group: stop taking Ozempic before surgery

explore

Dobbs anniversary: the lost opportunity of abortion as health care

NathanHoward/GettyImagesReflectingonthisfirstanniversaryoftheSupremeCourt’sdecisioninDobbstooverturn

WuXi Biologics execs register to lobby as Congress comes for the company

AdobeWASHINGTON—WuXiBiologicsexecutiveshavejoinedthelobbyingfrayinthelead-uptoamovebyCongresstoaddth

BioMarin wins approval for gene therapy to treat hemophilia A

AdobeTheFoodandDrugAdministrationonThursdayapprovedagenetherapytotreatpeoplewithhemophiliaA,aninheri

NFL doctors' conflicts of interest could endanger players, report says

CharlesRexArbogast/APDoctorsthatworkforprofessionalfootballteamshaveconflictsofinterestthatcouldjeop